JAK2 and breast carcinoma: STAT3 is an oncogenic transcription factor that is downstream of Janus-activated kinase 2 (JAK2), a non-receptor tyrosine kinase commonly amplified and hyperactive in TNBC and HER2-enriched breast cancers [260,261,262].